Last checked at 11 May 2021 17:50
IN BRIEF: Physiomics wins first contract from Numab Therapeutics
IN BRIEF: Physiomics wins first contract from Numab Therapeutics
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Physiomics Share News (PYC)
PYC Share
Price
PYC Share
News
PYC Share
Chat10
PYC Share
Trades4
PYC
Live RNS
PYC Share
Charts
PYC Level 2
Console
PYC Live
Share Price
PYC Broker
Ratings
PYC Directors
Deals
PYC Financial
Diary
PYC
Fundamentals
PYC Short
Positions
PYC
Media
Physiomics Information
Share Price Information for Physiomics (PYC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1.50
Bid:
1.40
Ask:
1.60
Change:
0.00 (0.00%)
Spread:
0.20 (14.286%)
Open:
1.50
High:
1.50
Low:
1.50
Prev. Close:
1.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.11 May 2021 10:46
Physiomics secures contract with Numab Therapeutics
(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.
Read more10 May 2021 10:21
Physiomics says full-year results to disappoint market forecasts
Physiomics says full-year results to disappoint market forecasts
Read more10 May 2021 10:19
AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake
AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake
Read more10 May 2021 08:40
Physiomics FY income likely to fall short of market expectations
(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.
Read more1 Mar 2021 11:29
AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes
AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes
Read more1 Mar 2021 11:22
TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit
TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit
Read more15 Feb 2021 16:04
Physiomics and ValiRx enter new collaboration deal
(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.
Read more15 Feb 2021 11:05
IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics
IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics
Read more17 Dec 2020 15:52
UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand
UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand
Read more17 Dec 2020 13:59
Physiomics gets initial 2021 commitment from client Merck
(Sharecast News) - Oncology consultancy Physiomics announced on Thursday that its existing client, Merck, has committed to an initial tranche of projects for 2021 with a total value of £0.27m.
Read more14 Dec 2020 19:35
UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares
UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares
Read more10 Nov 2020 15:43
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more16 Oct 2020 16:37
IN BRIEF: Physiomics Pens New Merck KGaA, Bicycle Therapeutics Deals
IN BRIEF: Physiomics Pens New Merck KGaA, Bicycle Therapeutics Deals
Read more16 Oct 2020 09:30
Physiomics awarded further contracts with Bicycle Therapeutics and Merck
(Sharecast News) - Oncology consultancy Physiomics has been awarded further contracts of an undisclosed value for projects with existing clients Bicycle Therapeutics and Merck.
Read more